Chronic Pain Market Size: Epidemiology, Growth, Scope, Structure, Opportunity and Forecast till (2023-2033)

The newly published report by IMARC Group, titled, ”Chronic Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033″, presents a comprehensive assessment of the chronic pain market size. The report provides an overview of the market trends, growth prospects, investment opportunities, and industry prospects, as well as an analysis of the disease overview, market scenario, and growth trends.

Chronic pain represents the pain that persists over three months owing to bone inflammation or damaged nerves from surgeries, underlying health conditions, or accidents. This condition affects both the physical and mental health of patients leading to depression, insomnia, and anxiety.

Chronic pain treatments mostly involve the usage of various devices and drugs, including opioids, non-steroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, etc. These treatment options help in managing the symptoms, such as muscle aches, burning pain, fatigue, loss of stamina, etc. Consequently, chronic pain therapies are extensively used across the globe.

Request a Free Sample Report: https://www.imarcgroup.com/chronic-pain-market/requestsample

Market Trend:

The expanding geriatric population and the growing prevalence of chronic diseases, including multiple sclerosis, osteoarthritis, diabetic neuropathy, cancer, etc., are among the key factors driving the chronic pain market. In line with this, the elevating cases of musculoskeletal ailments are acting as significant growth-inducing factors. Apart from this, the escalating demand for over-the-counter medications and the increasing improvements in the networking of retail pharmacies are also positively influencing the global market.

In addition to this, the shifting preferences toward alternative pain relief therapies to prevent the potential implication of prolonged use of pain treatment drugs are further stimulating the market growth. Moreover, the rising investments by leading market players in research and development (R&D) activities to introduce analgesics or painkillers that are easier to administer, more effective, and economically viable, and the launch of numerous wearable pain management devices and medical implants to ensure superior pain alleviation are expected to propel the chronic pain market over the forecasted period.

Report Period:

Base Year: 2022

Historical Period: 2017-2022

Market Forecast: 2023-2033

Countries Included:

United States

Germany

France

United Kingdom

Italy

Spain

Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario

Historical, current, and future performance of the chronic pain market

Historical, current, and future performance of various therapeutic categories in the market

Sales of various drugs across the chronic pain market

Reimbursement scenario in the market

In-market and pipeline drugs

In-Market Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview

Mechanism of Action

Regulatory Status

Clinical Trial Results

Regulatory Status

Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/chronic-pain-market

Key Questions Answered in this Report:

How has the chronic pain market performed so far and how will it perform in the coming years?

What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?

What was the country-wise size of the chronic pain market across the seven major markets in 2022 and what will it look like in 2033?

What is the growth rate of the chronic pain market across the seven major markets and what will be the expected growth over the next ten years?

What are the key unmet needs in the market?

About Us: –

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St.

Brooklyn, NY 11249, USA

Email: [email protected]

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800